GLOBUS MEDICAL INC
For the period ended Dec 31, 2025. Filed Feb 24, 2026.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2025 · Filed Feb 24, 2026
GMED$75.23-1.5%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Consolidated Statements of Operations and Comprehensive Income
| Year Ended | |||
|---|---|---|---|
| December 31, | |||
| (In thousands, except per share amounts) | 2025 | 2024 | 2023 |
| Net sales | $2,938,931 | $2,519,355 | $1,568,476 |
| Cost of Sales and Operating expenses: | |||
| Cost of sales (exclusive of amortization of intangibles) | 957,802 | 1,035,479 | 548,174 |
| Research and development | 147,246 | 163,754 | 124,010 |
| Selling, general and administrative | 1,178,498 | 981,362 | 643,844 |
| Amortization of intangibles | 118,194 | 119,373 | 51,032 |
| Acquisition-related costs | 42,326 | 29,623 | 68,274 |
| Restructuring costs | 15,049 | 23,773 | — |
| Operating income/(loss) | 479,816 | 165,991 | 133,142 |
| Other income/(expense), net: | |||
| Interest income/(expense), net | 7,141 | (4,189) | 20,130 |
| Foreign currency transaction gain/(loss) | (3,006) | (43,285) | 14,259 |
| Bargain purchase gain | 117,704 | — | — |
| Other income/(expense) | 3,413 | 2,205 | (2,138) |
| Total other income/(expense), net | 125,252 | (45,269) | 32,251 |
| Income/(loss) before income taxes | 605,068 | 120,722 | 165,393 |
| Income tax provision/(benefit) | 67,200 | 17,738 | 42,520 |
| Net income/(loss) | $537,868 | $102,984 | $122,873 |
| Other comprehensive income/(loss), net of tax: | |||
| Unrealized gain/(loss) on marketable securities | 448 | 1,545 | 13,231 |
| Foreign currency translation gain/(loss) | 21,759 | 1,786 | 1,207 |
| Total other comprehensive income/(loss), net of tax | 22,207 | 3,331 | 14,438 |
| Comprehensive income/(loss) | $560,075 | $106,315 | $137,311 |
| Earnings per share: | |||
| Basic | $3.98 | $0.76 | $1.09 |
| Diluted | $3.92 | $0.75 | $1.07 |
| Weighted average shares outstanding: | |||
| Basic | 135,215 | 135,726 | 113,087 |
| Diluted | 137,056 | 137,863 | 114,630 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.